| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.137 | 8.418 | 5.738 | 9.231 | 5.750 | 643 | 0 | 5.479 | 7.808 | 5.876 |
| Total Income - EUR | 8.137 | 8.418 | 5.738 | 9.231 | 5.750 | 643 | 0 | 5.479 | 7.808 | 5.876 |
| Total Expenses - EUR | 9.753 | 8.129 | 9.607 | 11.074 | 10.814 | 3.218 | 1.314 | 10.173 | 7.569 | 5.506 |
| Gross Profit/Loss - EUR | -1.616 | 289 | -3.869 | -1.843 | -5.064 | -2.575 | -1.314 | -4.694 | 239 | 370 |
| Net Profit/Loss - EUR | -1.860 | 120 | -3.926 | -1.936 | -5.122 | -2.582 | -1.314 | -4.785 | 123 | 252 |
| Employees | 1 | 1 | 1 | 2 | 2 | 1 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Biosalinda Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.547 | 1.141 | 794 | 457 | 132 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 198 | 593 | 72 | 1.244 | 111 | 139 | 235 | 231 | 80 | 392 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Cash | 198 | 537 | 17 | 1.190 | 59 | 87 | 185 | 180 | 30 | 341 |
| Shareholders Funds | -886 | -757 | -4.670 | -6.520 | -11.516 | -13.879 | -14.885 | -19.716 | -19.533 | -19.172 |
| Social Capital | 65 | 65 | 63 | 62 | 61 | 60 | 59 | 59 | 59 | 58 |
| Debts | 2.630 | 2.491 | 5.536 | 8.221 | 11.759 | 14.018 | 15.121 | 19.947 | 19.613 | 19.563 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9623 - 9623" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Biosalinda Srl